One of the variables with the effects of cancer is hypoxia, and a PET-based imaging technique may be capable of measuring and mapping it. Researchers at Washington University in St. Louis are focusing on two aspects of the investigational PET probe Cu-62 ATSM for hypoxia imaging.

Significant elevations in blood levels of amyloid beta 42 peptide, were detected by Single Molecule Array (SiMoA) technology in patients who experienced hypoxia following cardiac arrest, according to results presented this week at the American Academy of Neurology annual meeting held in Honolulu.